(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 19.24% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.25%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Astrana Health's revenue in 2024 is $1,386,661,000.On average, 4 Wall Street analysts forecast ASTH's revenue for 2024 to be $98,534,616,760, with the lowest ASTH revenue forecast at $95,250,668,989, and the highest ASTH revenue forecast at $100,643,366,587. On average, 4 Wall Street analysts forecast ASTH's revenue for 2025 to be $118,715,554,351, with the lowest ASTH revenue forecast at $112,149,266,088, and the highest ASTH revenue forecast at $130,217,297,096.
In 2026, ASTH is forecast to generate $123,433,471,957 in revenue, with the lowest revenue forecast at $123,433,471,957 and the highest revenue forecast at $123,433,471,957.